Our website uses cookies for functional and marketing purposes.
Read more about our Policy.
Reject
Accept
Menu
About
Approach
Team
Portfolio
Responsibility
News
Contact
Investor Login
News
Home
/
News
News
Ligand To Spin-Off Its OmniAb Business Through Merger With Avista Public Acquisition Corp. II
March 23, 2022
Neil Ferguson Joins Avista Capital Partners as a Strategic Executive
March 10, 2022
UBC Announces Acquisition of MarketShare Movers (“MSM”)
March 9, 2022
Optinose Reports Positive Top-line Results in ReOpen1, a Landmark Phase 3 Trial for XHANCE in Chronic Sinusitis
March 7, 2022
Avista Capital Partners to Acquire Probo Medical
February 15, 2022
Private Equity Industry’s First-Ever ESG Data Convergence Project Announces Milestone Commitment of Over 100 LPs and GPs
January 28, 2022
Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker Symbol “RVLP,” Plans to Launch UPNEEQ® into the Medical Aesthetics Market, and Provides Fourth Quarter 2022 Net Sales Guidance
January 26, 2022
Cosette Pharmaceuticals Acquires Rights to Eight Branded Products from Daiichi Sankyo
January 18, 2022
‹
1
…
3
4
5
6
7
…
24
›